SCINAI IMMUNOTHERAPEUTICS LTD. Cash Flows From Used In Operating Activities
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Cash Flows From Used In Operating Activities of -ILS 10.41 million for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in operating activities for the quarter ending 2022-06-30 was -10.41M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in operating activities for the quarter ending 2021-12-31 was -6.52M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in operating activities for the quarter ending 2021-09-30 was -6.19M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in operating activities for the quarter ending 2021-06-30 was -7.91M ILS.
ILS
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -10.41M ILS 6-K/A · filed 2022-08-29 | -14.80M ILS 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | -6.52M ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | -12.71M ILS derived: sum of 2 quarters · filed 2022-08-29 | -20.62M ILS derived: sum of 3 quarters · filed 2022-08-29 | -24.48M ILS 6-K/A · filed 2022-08-29 |
| 2021-09-30 | -6.19M ILS 6-K/A · filed 2021-12-27 | -14.10M ILS derived: sum of 2 quarters · filed 2022-08-29 | -17.96M ILS 6-K/A · filed 2021-12-27 | |
| 2021-06-30 | -7.91M ILS 6-K/A · filed 2022-08-29 | -11.77M ILS 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | -15.91M ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -26.22M ILS derived: sum of 2 quarters · filed 2022-03-28 | -38.06M ILS derived: sum of 3 quarters · filed 2022-03-28 | -72.54M ILS 20-F · filed 2022-03-28 |
| 2020-09-30 | -10.31M ILS 6-K/A · filed 2021-12-27 | -22.15M ILS derived: sum of 2 quarters · filed 2021-12-27 | -56.63M ILS 6-K/A · filed 2021-12-27 | |
| 2020-06-30 | -11.84M ILS 6-K · filed 2020-10-02 | -46.32M ILS 6-K · filed 2020-10-02 | ||
| 2019-12-31 | -17.05M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | -41.98M ILS derived: sum of 2 quarters · filed 2022-03-28 | -63.83M ILS derived: sum of 3 quarters · filed 2022-03-28 | -77.06M ILS 20-F · filed 2022-03-28 |
| 2019-09-30 | -24.93M ILS 6-K · filed 2021-01-28 | -46.78M ILS derived: sum of 2 quarters · filed 2021-01-28 | -60.01M ILS 6-K · filed 2021-01-28 | |
| 2019-06-30 | -21.85M ILS 6-K · filed 2020-10-02 | -35.08M ILS 6-K · filed 2020-10-02 | ||
| 2018-12-31 | -57.19M ILS 20-F · filed 2021-05-13 | |||
| 2017-12-31 | -10.05M ILS 20-F · filed 2020-06-12 | |||
| 2016-12-31 | -9.65M ILS 20-F · filed 2019-04-30 | |||
| 2015-12-31 | -10.27M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$4.23M 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | -$2.31M derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -$7.87M 20-F · filed 2022-03-28 | ||
| 2021-09-30 | -$5.56M 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$22.56M 20-F · filed 2021-05-13 | |||
| 2017-12-31 | -$2.90M 20-F · filed 2018-04-30 |